Cargando…

MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses

BACKGROUND: The availability of a universal influenza vaccine able to induce broad cross-reactive immune responses against diverse influenza viruses would provide an alternative to currently available strain-specific vaccines. We evaluated the ability of vectors based on modified vaccinia virus Anka...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hessel, Annett, Savidis-Dacho, Helga, Coulibaly, Sogue, Portsmouth, Daniel, Kreil, Thomas R., Crowe, Brian A., Schwendinger, Michael G., Pilz, Andreas, Barrett, P. Noel, Falkner, Falko G., Schäfer, Birgit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921149/ https://www.ncbi.nlm.nih.gov/pubmed/24523886 http://dx.doi.org/10.1371/journal.pone.0088340

Ejemplares similares

Vectors Based on Modified Vaccinia Ankara Expressing Influenza H5N1 Hemagglutinin Induce Substantial Cross-Clade Protective Immunity
por: Hessel, Annett, et al.
Publicado: (2011)

A Pandemic Influenza H1N1 Live Vaccine Based on Modified Vaccinia Ankara Is Highly Immunogenic and Protects Mice in Active and Passive Immunizations
por: Hessel, Annett, et al.
Publicado: (2010)

H5N1 Whole-Virus Vaccine Induces Neutralizing Antibodies in Humans Which Are Protective in a Mouse Passive Transfer Model
por: Howard, M. Keith, et al.
Publicado: (2011)

A Whole Virus Pandemic Influenza H1N1 Vaccine Is Highly Immunogenic and Protective in Active Immunization and Passive Protection Mouse Models
por: Kistner, Otfried, et al.
Publicado: (2010)

Immunogenicity and Protective Efficacy of a Vero Cell Culture-Derived Whole-Virus H7N9 Vaccine in Mice and Guinea Pigs
por: Wodal, Walter, et al.
Publicado: (2015)

Evaluation of OspA Vaccination-Induced Serological Correlates of Protection against Lyme Borreliosis in a Mouse Model
por: Schwendinger, Michael G., et al.
Publicado: (2013)

Pre-Clinical Efficacy and Safety of Experimental Vaccines Based on Non-Replicating Vaccinia Vectors against Yellow Fever
por: Schäfer, Birgit, et al.
Publicado: (2011)

Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID mice
por: Hohenadl, Christine, et al.
Publicado: (2014)

Neuraminidase-Inhibiting Antibody Response to H5N1 Virus Vaccination in Chronically Ill and Immunocompromised Patients
por: Fritz, Richard, et al.
Publicado: (2014)

Selection of recombinant MVA by rescue of the essential D4R gene
por: Ricci, Patricia S, et al.
Publicado: (2011)

Avian flu virus H5N1: No proof for existence, pathogenicity, or pandemic potential; non-“H5N1” causation omitted
por: Crowe, David, et al.
Publicado: (2006)

Influenza Antigens NP and M2 Confer Cross Protection to BALB/c Mice against Lethal Challenge with H1N1, Pandemic H1N1 or H5N1 Influenza A Viruses
por: Mytle, Nutan, et al.
Publicado: (2021)

MVA-Based H5N1 Vaccine Affords Cross-Clade Protection in Mice against Influenza A/H5N1 Viruses at Low Doses and after Single Immunization
por: Kreijtz, Joost H. C. M., et al.
Publicado: (2009)

Increased Inflammatory Signaling and Lethality of Influenza H1N1 by Nuclear Thioredoxin-1
por: Go, Young-Mi, et al.
Publicado: (2011)

In Silico Identification of Highly Conserved Epitopes of Influenza A H1N1, H2N2, H3N2, and H5N1 with Diagnostic and Vaccination Potential
por: Muñoz-Medina, José Esteban, et al.
Publicado: (2015)

Human Avian Influenza A H5N1, H7N9, H10N8 and H5N6 Virus Infection
por: Lu, Pu-Xuan, et al.
Publicado: (2015)

H5N1
por: Petsko, Gregory A
Publicado: (2005)

Inactivated H5 Antigens of H5N8 Protect Chickens from Lethal Infections by the Highly Pathogenic H5N8 and H5N6 Avian Influenza Viruses
por: Jin, Myongha, et al.
Publicado: (2018)

A single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus
por: Chang, Haiyan, et al.
Publicado: (2010)

Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1
por: Wang, Chen, et al.
Publicado: (2014)

Immunization with 1976 swine H1N1‐ or 2009 pandemic H1N1‐inactivated vaccines protects mice from a lethal 1918 influenza infection
por: Easterbrook, Judith D., et al.
Publicado: (2011)

Protection of Mice against Lethal Challenge with 2009 H1N1 Influenza A Virus by 1918-Like and Classical Swine H1N1 Based Vaccines
por: Manicassamy, Balaji, et al.
Publicado: (2010)

Molecular modeling of swine influenza A/H1N1, Spanish H1N1, and avian H5N1 flu N1 neuraminidases bound to Tamiflu and Relenza
por: Le, Ly, et al.
Publicado: (2011)

2009-H1N1
por: Al-Hajjar, Sami
Publicado: (2012)

Comparative pathology of pigs infected with Korean H1N1, H1N2, or H3N2 swine influenza A viruses
por: Lyoo, Kwang-Soo, et al.
Publicado: (2014)

Seroprevalence of H1N1, H3N2 and H1N2 influenza viruses in pigs in seven European countries in 2002–2003
por: Van Reeth, Kristien, et al.
Publicado: (2008)

Comparative study of pandemic (H1N1) 2009, swine H1N1, and avian H3N2 influenza viral infections in quails
por: Thontiravong, Aunyaratana, et al.
Publicado: (2012)

Infection of Human Airway Epithelia with H1N1, H2N2, and H3N2 Influenza A Virus Strains
por: Slepushkin, Vladimir A., et al.
Publicado: (2001)

Comparison of patients hospitalized with COVID-19, H7N9 and H1N1
por: Deng, Li-Si, et al.
Publicado: (2020)

Highly pathogenic avian influenza virus incursions of subtype H5N8, H5N5, H5N1, H5N4, and H5N3 in Germany during 2020-21
por: King, Jacqueline, et al.
Publicado: (2022)

Comparative Pathogenicity and Transmissibility of Pandemic H1N1, Avian H5N1, and Human H7N9 Influenza Viruses in Tree Shrews
por: Xu, Shuai, et al.
Publicado: (2019)

Introductions of Human-Origin Seasonal H3N2, H1N2 and Pre-2009 H1N1 Influenza Viruses to Swine in Brazil
por: Tochetto, Caroline, et al.
Publicado: (2023)

Age- Matched Comparison of Children Hospitalized for 2009 Pandemic H1N1 Influenza with Those Hospitalized for Seasonal H1N1 and H3N2
por: Chiu, Susan S., et al.
Publicado: (2011)

Soluble Recombinant Hemagglutinin Protein of H1N1pdm09 Influenza Virus Elicits Cross-Protection Against a Lethal H5N1 Challenge in Mice
por: Yamada, Shinya, et al.
Publicado: (2019)

SARS and H5N1
por: Bindenagel Šehović, Annamarie
Publicado: (2017)

Neuraminidase inhibitors sensitivity in Cambodian H5N1 and H1N1 pandemic influenza viruses
por: Naughtin, M, et al.
Publicado: (2011)

Protein intrinsic disorder and influenza virulence: the 1918 H1N1 and H5N1 viruses
por: Goh, Gerard Kian-Meng, et al.
Publicado: (2009)

Comparative Analyses of Pandemic H1N1 and Seasonal H1N1, H3N2, and Influenza B Infections Depict Distinct Clinical Pictures in Ferrets
por: Huang, Stephen S. H., et al.
Publicado: (2011)

Prior Infection of Chickens with H1N1 or H1N2 Avian Influenza Elicits Partial Heterologous Protection against Highly Pathogenic H5N1
por: Nfon, Charles, et al.
Publicado: (2012)

H1N1: The dental perspective
por: Kapoor, Vinod
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vob6q6geupbql3vc0nmvp162mt